Brickell Biotech, Inc.

Brickell Biotech, Inc.verified

BBI

Price:

$2.35

Market Cap:

$5.59M

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Car...[Read more]

Industry

Biotechnology

IPO Date

1993-03-10

Stock Exchange

NASDAQ

Ticker

BBI

The Current Ratio as of December 2025 (TTM) for Brickell Biotech, Inc. (BBI) is 6.98

According to Brickell Biotech, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.98. This represents a change of 16.17% compared to the average of 6.00 of the last 4 quarters.

Brickell Biotech, Inc. (BBI) Historical Current Ratio (quarterly & annually)

How has BBI Current Ratio performed in the past?

The mean historical Current Ratio of Brickell Biotech, Inc. over the last ten years is 6.89. The current 6.98 Current Ratio has changed 10.02% with respect to the historical average. Over the past ten years (40 quarters), BBI's Current Ratio was at its highest in in the June 2019 quarter at 36.84. The Current Ratio was at its lowest in in the December 2019 quarter at 1.71.

Quarterly (TTM)
Annual

Average

6.89

Median

6.43

Minimum

1.71

Maximum

13.74

Brickell Biotech, Inc. (BBI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Brickell Biotech, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 208.32%

Maximum Annual Current Ratio = 13.74

Minimum Annual Increase = -87.54%

Minimum Annual Current Ratio = 1.71

Quarterly (TTM)
Annual
YearCurrent RatioChange
20236.98112.88%
20223.28-46.75%
20216.1516.60%
20205.28208.32%
20191.71-87.54%
201813.74204.55%
20174.51-32.66%
20166.70-37.34%
201510.698.33%
20149.87-37.93%

Brickell Biotech, Inc. (BBI) Average Current Ratio

How has BBI Current Ratio performed in the past?

The current Current Ratio of Brickell Biotech, Inc. (BBI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.47

5-year avg

4.68

10-year avg

6.89

Brickell Biotech, Inc. (BBI) Current Ratio vs. Peers

How is BBI’s Current Ratio compared to its peers?

Brickell Biotech, Inc.’s Current Ratio is greater than Kineta, Inc. (0.06), greater than Omega Therapeutics, Inc. (1.61), greater than Tvardi Therapeutics, Inc. (3.48), greater than Entero Therapeutics, Inc. (2.62), greater than Star Equity Holdings, Inc. (2.07), greater than Biora Therapeutics, Inc. (0.05), greater than Tricida, Inc. (4.94), greater than Turnstone Biologics Corp. (3.33), greater than Longevity Health Holdings Inc. (0.42), greater than COSCIENS Biopharma Inc. (2.98),

Build a custom stock screener for Brickell Biotech, Inc. (BBI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Brickell Biotech, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Brickell Biotech, Inc. (BBI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Brickell Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Brickell Biotech, Inc.'s Current Ratio?

How is the Current Ratio calculated for Brickell Biotech, Inc. (BBI)?

What is the highest Current Ratio for Brickell Biotech, Inc. (BBI)?

What is the 3-year average Current Ratio for Brickell Biotech, Inc. (BBI)?

What is the 5-year average Current Ratio for Brickell Biotech, Inc. (BBI)?

How does the current Current Ratio for Brickell Biotech, Inc. (BBI) compare to its historical average?